499 related articles for article (PubMed ID: 19208749)
21. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
23. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells.
Xu W; Yuan X; Jung YJ; Yang Y; Basso A; Rosen N; Chung EJ; Trepel J; Neckers L
Cancer Res; 2003 Nov; 63(22):7777-84. PubMed ID: 14633703
[TBL] [Abstract][Full Text] [Related]
24. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2.
Gulliford TJ; Huang GC; Ouyang X; Epstein RJ
Oncogene; 1997 Oct; 15(18):2219-23. PubMed ID: 9393980
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
Kapoor GS; Kapitonov D; O'Rourke DM
Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
[TBL] [Abstract][Full Text] [Related]
26. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling.
Scheving LA; Zhang L; Stevenson MC; Kwak ES; Russell WE
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G16-25. PubMed ID: 16769812
[TBL] [Abstract][Full Text] [Related]
27. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
[TBL] [Abstract][Full Text] [Related]
28. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
29. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
Pagano E; Calvo JC
J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
[TBL] [Abstract][Full Text] [Related]
30. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
Ram TG; Schelling ME; Hosick HL
Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
[TBL] [Abstract][Full Text] [Related]
31. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
Weng MS; Ho CT; Ho YS; Lin JK
Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
[TBL] [Abstract][Full Text] [Related]
32. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
[TBL] [Abstract][Full Text] [Related]
33. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
Ishizawar RC; Miyake T; Parsons SJ
Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of type I growth factor receptors in pterygium.
Liu Z; Xie Y; Zhang M
Chin Med J (Engl); 2002 Mar; 115(3):418-21. PubMed ID: 11940379
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism.
Huang G; Chantry A; Epstein RJ
J Cell Biochem; 1999 Jul; 74(1):23-30. PubMed ID: 10381258
[TBL] [Abstract][Full Text] [Related]
36. Tephrosin induces internalization and degradation of EGFR and ErbB2 in HT-29 human colon cancer cells.
Choi S; Choi Y; Dat NT; Hwangbo C; Lee JJ; Lee JH
Cancer Lett; 2010 Jul; 293(1):23-30. PubMed ID: 20056314
[TBL] [Abstract][Full Text] [Related]
37. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.
Xia W; Liu LH; Ho P; Spector NL
Oncogene; 2004 Jan; 23(3):646-53. PubMed ID: 14737100
[TBL] [Abstract][Full Text] [Related]
38. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
Dote H; Cerna D; Burgan WE; Camphausen K; Tofilon PJ
Cancer Res; 2005 Aug; 65(15):6967-75. PubMed ID: 16061682
[TBL] [Abstract][Full Text] [Related]
39. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines.
Park JW; Yeh MW; Wong MG; Lobo M; Hyun WC; Duh QY; Clark OH
J Clin Endocrinol Metab; 2003 Jul; 88(7):3346-53. PubMed ID: 12843186
[TBL] [Abstract][Full Text] [Related]
40. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
